EliTech to Distribute Curetis Unyvero Products in Belgium, Luxembourg | GenomeWeb

NEW YORK (GenomeWeb News) – Molecular diagnostics company Curetis today announced a deal with EliTech BNL to distribute its products in Belgium and Luxembourg.

Terms of the deal were not disclosed.

EliTech BNL, formerly call Lucron Bioproducts, is part of the EliTech Group and supported Cepheid's entry into the Benelux market, Curetis said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.